Seres Therapeutics Inc.

NASDAQ: MCRB · Real-Time Price · USD
16.70
-0.16 (-0.95%)
At close: Aug 15, 2025, 3:47 PM

Seres Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a 126.33M 7.13M 144.93M
Cost of Revenue
n/a 704K 1M 1.73M
Gross Profit
n/a 125.62M 6.12M 143.19M
Operating Income
-121.31M -107.98M -246.49M -64.49M
Interest Income
3.97M 7.3M 3.06M 2.87M
Pretax Income
136K -113.72M -250.16M -65.58M
Net Income
136K -113.72M -253.82M -61.5M
Selling & General & Admin
53.18M 87.74M 79.69M 69.26M
Research & Development
64.6M 145.86M 172.92M 141.89M
Other Expenses
3.53M n/a 1M -1.73M
Operating Expenses
121.31M 233.6M 253.62M 209.42M
Interest Expense
n/a 13.18M 6.02M 2.91M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 234.31M 253.62M 209.42M
Income Tax Expense
n/a n/a 3.67M -4.08M
Shares Outstanding (Basic)
155.4M 128M 108.08M 4.59M
Shares Outstanding (Diluted)
7.77M 128M 108.08M 4.59M
EPS (Basic)
0.00 -0.89 -2.35 -0.67
EPS (Diluted)
0.00 -0.89 -2.35 -0.67
EBITDA
-121.31M -94.31M -237.51M -56.72M
EBIT
-125.77M -100.55M -244.14M -62.67M
Depreciation & Amortization
n/a 6.24M 11.85M 9.22M